Literature DB >> 20418900

Highlight dementia risk to reduce CVD.

Bryony M Mearns, Valentin Fuster.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20418900     DOI： 10.1038/nrcardio.2010.37

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  4 in total

1.  Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.

Authors:  H H Feldman; R S Doody; M Kivipelto; D L Sparks; D D Waters; R W Jones; E Schwam; R Schindler; J Hey-Hadavi; D A DeMicco; A Breazna
Journal:  Neurology       Date:  2010-03-03       Impact factor: 9.910

2.  Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.

Authors:  D Larry Sparks; Marwan N Sabbagh; Donald J Connor; Jean Lopez; Lenore J Launer; Suzana Petanceska; Patrick Browne; Dawn Wassar; Sherry Johnson-Traver; Jeff Lochhead; Chuck Ziolkowski
Journal:  Curr Alzheimer Res       Date:  2005-07       Impact factor: 3.498

3.  Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease.

Authors:  M E Risner; A M Saunders; J F B Altman; G C Ormandy; S Craft; I M Foley; M E Zvartau-Hind; D A Hosford; A D Roses
Journal:  Pharmacogenomics J       Date:  2006-01-31       Impact factor: 3.550

4.  Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population.

Authors:  Ihab Hajjar; Heath Catoe; Sherry Sixta; Rebecca Boland; David Johnson; Victor Hirth; Darryl Wieland; Paul Eleazer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-01       Impact factor: 6.053
  4 in total
  1 in total

Review 1.  A major role for cardiovascular burden in age-related cognitive decline.

Authors:  Chengxuan Qiu; Laura Fratiglioni
Journal:  Nat Rev Cardiol       Date:  2015-01-13       Impact factor: 32.419
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.